Argyle Capital Partners, LLC
Position in GALT — Galectin Therapeutics Inc
CIK 2079995
LOS ANGELES, CA
Position in GALT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$62,060
+$24,744 QoQ
Shares Held
13,375
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#67
of 98 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $62,060 across 1 Biotechnology name. GALT ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
This page
|
13,375 | $62,060 |
All Filings in GALT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,060 | 13,375 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $37,316 | 13,375 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $55,640 | 13,375 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $56,710 | 13,375 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,221 | 13,375 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,317 | 13,375 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $17,253 | 13,375 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||